InvestorsHub Logo
Followers 4
Posts 2113
Boards Moderated 0
Alias Born 10/17/2022

Re: None

Friday, 01/19/2024 12:34:28 PM

Friday, January 19, 2024 12:34:28 PM

Post# of 19062
$TSPG has entered into a research and development agreement with ELA Pharma (ELA) https://www.elapharma.com/. This strategic collaboration is set to develop innovative cell death therapy treatments for the veterinary industry.

The partnership between BIOVET CGT and ELA Pharma focuses on the development and utilization of smart, intelligent medical treatments. These treatments are based on cell death therapy, a novel approach in veterinary medicine. The collaboration will involve the development of new products and projects, which will be jointly undertaken by both companies.
Bullish
Bullish